Cargando…
Deprescribing in Palliative Cancer Care
The aim of palliative care is to maintain as high a quality of life (QoL) as possible despite a life-threatening illness. Thus, the prescribed medications need to be evaluated and the benefit of each treatment must be weighed against potential side effects. Medications that contribute to symptom rel...
Autores principales: | Hedman, Christel, Frisk, Gabriella, Björkhem-Bergman, Linda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147815/ https://www.ncbi.nlm.nih.gov/pubmed/35629281 http://dx.doi.org/10.3390/life12050613 |
Ejemplares similares
-
Evaluation of Whole Brain Radiotherapy among Lung Cancer Patients with Brain Metastases in Relation to Health Care Level and Survival
por: Frisk, Gabriella, et al.
Publicado: (2022) -
Palliative Sedation—The Last Resort in Case of Difficult Symptom Control: A Narrative Review and Experiences from Palliative Care in Switzerland
por: Camartin, Cristian, et al.
Publicado: (2022) -
Fatigue in Cancer Patients in Palliative Care—A Review on Pharmacological Interventions
por: Klasson, Caritha, et al.
Publicado: (2021) -
25-Hydroxyvitamin D in Cancer Patients Admitted to Palliative Care: A Post-Hoc Analysis of the Swedish Trial ‘Palliative-D’
por: Helde Frankling, Maria, et al.
Publicado: (2022) -
Sex-Differences in Discontinuation of Statin Treatment in Cancer Patients the Year before Death
por: Frisk, Gabriella, et al.
Publicado: (2021)